DeuterOncology is a Belgium-based preclinical-stage biotech company that develops and commercializes novel therapeutics for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 1-10
Address: Oudepostelseweg 1
City: Geel
State: flemish brabant
Zip: 2440
Country: BE
DeuterOncology is a Belgium-based preclinical-stage biotech company that develops and commercializes novel therapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2023 | Series A | $6.1M |
Newton Biocapital , Noshaq Investsud Tech. |
1/2023 | Series A | $0 |
Noshaq Newton Biocapital Investsud Meusinvest (Noshaq) Meusinvest (Noshaq) Noshaq Newton Biocapital Investsud Meusinvest (Noshaq) Meusinvest (Noshaq) |
2/2021 | Venture Round | - | 2/2021 | Seed Round | - |
Newton Biocapital Newton Biocapital |
2/2021 | Venture Round | - |
Newton Biocapital Newton Biocapital |
2/2021 | Seed Round | 1 | - |
Newton Biocapital Newton Biocapital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|